SCI Abstract

search
+
Treat-to-Target in Atopic Dermatitis
Treat-to-Target in Atopic Dermatitis
Atopic dermatitis is one of the most common inflammatory skin diseases among children and adults. Over the last 5 years, t...
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic
Utilization of telemedicine for dermatology has greatly expanded since the start of the COVID-19 pandemic, with over 500 n...
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy
Basal cell carcinoma (BCC) is the most common skin cancer, for which there are multiple treatment options, including the g...
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
Cutaneous T-cell lymphomas are a heterogenous group of lymphomas that cause various skin manifestations. Severe pruritus o...
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives
Hormonal and immunologic changes during pregnancy can contribute to the development of different dermatoses, the most comm...
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyLuca Stingeni, Rossella Mari...
Non-invasive Skin Imaging in Cutaneous Lymphomas
Non-invasive Skin Imaging in Cutaneous Lymphomas
The diagnosis of cutaneous lymphomas is challenging and requires skin tissue for histology and immunophenotyping using imm...
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taoyuan, TaiwanChia-Ling Yu & Li-Huei ChiangDepartment o...
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Investigator’s Global Assessment of clear/almost clear skin (IGA 0/1) is a difficult endpoint to achieve after short...
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Treatment of moderate-to-severe plaque psoriasis with biologics, such as guselkumab, has demonstrated greater efficacy ove...
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Chronic prurigo (CPG) is a neuroinflammatory, fibrotic dermatosis that is defined by the presence of chronic pruritus (itc...
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
AtopyReg® is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatit...
Oral Lichen Planus: An Update on Diagnosis and Management
Oral Lichen Planus: An Update on Diagnosis and Management
Oral lichen planus (OLP) is a chronic inflammatory disease whose pathogenesis involves a T-cell mediated, epithelium-direc...
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Atopic dermatitis (AD) is a chronic inflammatory disease requiring efficacious and safe long-term therapy. Several new sys...
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Infammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Infammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taoyuan, TaiwanChia-Ling Yu & Li-Huei ChiangDepartment o...
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Two phase III trials, ECZTRA 1 and 2, confirmed the efficacy and safety of tralokinumab versus placebo in adults with mode...
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma
Histopathologic characteristics (HC) are a mainstay in melanoma prognosis; gene expression profiling (GEP) has emerged as ...
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2
Abrocitinib, an oral, once-daily Janus kinase 1-selective inhibitor, improved itch severity, sleep, and work productivity ...
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights
Funding No funding was received for the preparation of this article...
Alopecia Areata: Current Treatments and New Directions
Alopecia Areata: Current Treatments and New Directions
Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at th...
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Larg...
Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management
Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management
There is an ongoing epidemic of chronic, relapsing dermatophytoses caused by Trichophyton indotineae that are unr...
Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis
Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis
Alopecia areata (AA) is a complex autoimmune condition resulting in nonscarring hair loss. In recent years, many studies h...
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies
The advent of protein kinase inhibitors and immunotherapy has profoundly improved the management of advanced melanoma. How...
Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database
Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database
Pustular psoriasis is a chronic and recurrent autoimmune disease, although little is known about the disease burden of pus...
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Funding None. Conflict of i...
Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Chen S, Chen Y. Comment on: “Isotretinoin exposure and risk of inflammatory bowel disease: a systematic review with meta-a...
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study
Hidradenitis suppurativa (HS) is a chronic, autoinflammatory skin disease associated with many comorbidities. One biologic...
Load More
format_indent_increase